Queen Mary - University of London

Barts and the London School of Medicine and Dentistry

Neuroscience and Translation Medicine


London, England

United Kingdom

Program Information

Degrees Offered:

Postgraduate Certificate/Diploma, Master of Science

Format: Campus

Program Description:

MSc/PGDip/PGCert One year full-time Programme description The aim of this postgraduate Translational Neuroscience programme, which is at present the first of its kind in the UK and Europe, is to provide a thorough training in the main concepts and methods of translational medicine, with a particular focus on unmet needs in diseases of the nervous system and the challenge of developing better therapies. At the end of their studies students will have a detailed knowledge of the drug discovery and development process, and of clinical trial design and methodology and the regulatory environment. The formal teaching takes place in the Neuroscience Centre at the Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, and includes lectures, seminars, clinical workshops and a research project. The lecturers are specialists in their field and are pre-clinical scientists and clinicians, and are internationally renowned as leaders in their field. There are also invited speakers, who are specialists from other UK or international academic institutions and senior scientists from the pharmaceutical industry. Programme outline The programme provides coverage of the following topics: Basic principles in neuroscience Mechanisms of disease and drug targets in the nervous system Unmet therapeutic needs in major disease areas in neurology Biomarkers of disease and their role in drug development Genomics, proteomics, metabolomics and systems biology and their impact in modern medicine Drug discovery Drug development Clinical trial design and regulatory requirements Intellectual property The taught programme starts with a core module which covers fundamental concepts in drug discovery and development, and continues with five special modules which cover comprehensively specific disease areas. The taught programme is delivered in two half-days per week, throughout the academic year. After the completion of the taught programme, students carry out a research project, which can be library-based, laboratory-based or clinically-based. Assessment The taught modules are assessed using a combination of final written examinations and a series of in-course assessments. The in-course assessments consist of literature reviews, oral presentations, case analyses and clinical trial protocols. They are designed as a learning experience as well as a test of knowledge. They represent 30 per cent of the module marks. The research project assessment is based on a written dissertation and an oral examination, which represent 85 per cent and 15 per cent of the mark, respectively. Entry requirements If you are a recent graduate in medicine, pharmacy or biomedical science, you are more likely to want to follow the full-time MSc programme. If you are a medical graduate, dentistry graduate, pharmacist or nurse, or scientist in the public or private sector, and are currently employed, the Postgraduate Certificate or Postgraduate Diploma may appeal more to you if you want a shorter programme of study, more compatible with full-time professional activity. Overseas students are encouraged to apply for the full-time MSc programme, the Postgraduate Certificate, or the Postgraduate Diploma. See the ‘International students’ section on page 390 for more information. Evidence of English proficiency is required of students for whom English is not their first language. A minimum overall score of 6.5 IELTS (or equivalent) is required.


Accredited university

Facts & Figures

International Financial Aid: No

Find Schools